Body iron metabolism and pathophysiology of iron overload. - Wikidata - wikimedia - TriplyDB

Body iron metabolism and pathophysiology of iron overload.

Body iron metabolism and pathophysiology of iron overload.

http://www.wikidata.org/entity/Q37205002

about

The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease MRI Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and Pitfalls Iron and zinc nutrition in the economically-developed world: a review Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases Hereditary hemochromatosis (HFE) genotypes in heart failure: relation to etiology and prognosis Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading β-thalassemic mice.Hepcidin and the iron enigma in HCV infection.Advances in iron chelation therapy: transitioning to a new oral formulation.Improved siderotic nodule detection in cirrhosis with susceptibility-weighted magnetic resonance imaging: a prospective study.Iron-binding proteins and C-reactive protein in Nipple Aspirate Fluids: role of Iron-driven inflammation in breast cancer microenvironment?Iron status in infants with alloimmune haemolytic disease in the first three months of life.Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway.HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study The dose-response association of urinary metals with altered pulmonary function and risks of restrictive and obstructive lung diseases: a population-based study in China.Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study.Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation.Impaired iron status in aging research Reducing iron accumulation: A potential approach for the prevention and treatment of postmenopausal osteoporosis Simultaneous field and R2 mapping to quantify liver iron content using autoregressive moving average modeling.Long-term perturbation of muscle iron homeostasis following hindlimb suspension in old rats is associated with high levels of oxidative stress and impaired recovery from atrophy.Increased Heme Levels in the Heart Lead to Exacerbated Ischemic Injury.Genetic variant coding for iron regulatory protein HFE contributes to hypertension, the TAMRISK study Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará, Brazil Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange.Microporation and 'iron'tophoresis for treating iron deficiency anemia.The role of S-methylisothiourea hemisulfate as inducible nitric oxide synthase inhibitor against kidney iron deposition in iron overload rats.Heme levels are increased in human failing hearts Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf area Reaction of hemoglobin with HOCl: mechanism of heme destruction and free iron release.The Effects of Nutrition, Exercise, and a Praying Program on Reducing Iron Overload in Patients With Beta-Thalassemia Major: A Randomized Clinical Trial.The emerging role of iron dyshomeostasis in the mitochondrial decay of aging.Deferasirox: pharmacokinetics and clinical experience.The dangers of iron overload: bring in the iron police.Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy.3-Hydroxypyridinone derivatives as metal-sequestering agents for therapeutic use.Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment.Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload.Alterations in differentially expressed genes after repeated exposure to perfluorooctanoate and perfluorooctanesulfonate in liver of Oryzias latipes.

P2860

Q26798153-06F9B8EB-B093-474C-9CCF-02066453D792 Q28072173-5EEB28B5-4FA1-4CD2-A9EF-6B207809F5CF Q28296541-04B8ADF4-9D42-4128-9B5E-3DE03F714151 Q28388335-FF8D8D14-12B7-441D-ABC9-3E698E14558C Q33644914-5C8D6E7F-DD2D-43CD-A6EA-C46FFBCFCB7B Q33682055-31FD6563-54F2-43D4-A83B-C0F627CD82D7 Q33779089-29A1D559-3649-4FDD-B3E6-20818F96B6EA Q33879123-EAC4A88F-F066-4E8C-9202-0612F9FB482D Q34270757-B56E9957-EFFD-41CD-8186-1A331332A93C Q34310274-5265273D-718E-415B-A3AD-DD6A73AC0730 Q34353677-DE6BAEEF-D2CF-4F3B-8D9A-11294E697AB8 Q34700903-09BC4620-B751-42DE-BCE6-A1228E9B2FD9 Q35112908-1DFD580B-FC23-4A3B-B14B-20F3F55DABB3 Q35199067-F40CA723-5334-411F-82EC-B065A1602366 Q35332467-64CD4091-81E9-46B5-9B3C-0223057DB966 Q35640569-64FC5B9E-7CB6-4E5A-B03D-44DD90050C12 Q35693595-BD0D71EB-483D-488C-8CBE-E58AE464CC3D Q35763055-D083A645-1990-441D-90E3-711F75D321DE Q35795910-A880E334-8834-4A0B-96EB-45C70E9DECED Q35803018-09196691-67FB-4F4E-A7FB-DCD19ECBE04A Q35848307-BF60BDFC-10D7-47CF-AF4E-1C6290EECD72 Q35984679-8E8E8436-15DB-4F4D-8D29-6098F2649C7E Q36141698-0D6B2C45-B81E-4C4D-8D61-416A6B84DF4A Q36153272-5305FC2E-C170-4CEF-8A36-8D796763FFE4 Q36153475-44460617-6CA0-440B-B697-4BA60BF03A8E Q36420464-65698567-A1E1-403D-97E9-7388E774980F Q36625891-FAF285D8-B80D-4E8A-95F4-3B6ECD64DA2B Q37006753-6FBE49E4-78F0-43BA-9EED-42B129772B0F Q37085606-A19AAF50-8210-4B5D-BD2A-30B0AFAB361C Q37359617-C81BC02C-ABBD-4E66-852C-961748C3F174 Q37393362-FEDA1577-F759-461F-98E8-3EB49E0E55D1 Q37631132-1F4D3761-98D6-4518-B40D-E863B90D662D Q37740429-F8C9B203-CB15-4A37-9A3C-A3078BF0841D Q37969225-A4083278-604A-4DDA-B33D-70B1E7B99AFA Q38001069-55AD0E7E-987E-4688-B761-B7584A63CC44 Q38242978-BB93DEE2-CBCF-4697-ABDD-AD2A1E439298 Q38397352-2F5CCD71-08BD-4FF2-A2BD-F32C8A2F98E7 Q38416115-59DC672B-F903-4225-9BAB-7288D302B997 Q38427850-4B4DDC48-8B62-4139-8ACF-40358A053D8B Q38455692-55262C4F-4623-4379-9C0A-E59B91F24F89

P2860

Body iron metabolism and pathophysiology of iron overload.

http://www.wikidata.org/entity/Q37205002

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Body iron metabolism and pathophysiology of iron overload.

@en

Body iron metabolism and pathophysiology of iron overload.

@nl

type

label

Body iron metabolism and pathophysiology of iron overload.

@en

Body iron metabolism and pathophysiology of iron overload.

@nl

prefLabel

Body iron metabolism and pathophysiology of iron overload.

@en

Body iron metabolism and pathophysiology of iron overload.

@nl

P1433

Q37205002-5D2158B1-C90C-4363-A2F8-1A2D05F0F4F7

P1476

Q37205002-71A26222-5AB0-4DDE-A9F7-C265147B8C13

P2093

Q37205002-036044DD-F5A8-4AAB-BD2C-D22DE03924F6

Q37205002-240E31D2-6C12-4443-8371-BA3B4CB3423C

Q37205002-8C762C08-0FB4-404B-95CC-1232E4D8BD59

Q37205002-CC8E31C1-5AE6-44EA-BC91-E022C86C659F

Q37205002-DB044536-53B2-43BE-8A3B-2232809B28C3

P2860

Q37205002-0DBECC9F-2E27-491D-859E-817C3ACDFB0C

Q37205002-1C633AB9-8FF5-48BD-AFD2-EC86143993C7

Q37205002-29B4B545-4B91-4EDB-94B4-71D2D2CA7E00

Q37205002-3E7CB9A2-7AA6-4182-B691-FF749E6C0A27

Q37205002-45B562BF-DCB0-4375-B6C7-ACBF6AA00C8C

Q37205002-50FB9B17-6BF0-46BD-B331-8A436731D6AC

Q37205002-539C1C23-02AC-464F-98F0-9FAC330895C9

Q37205002-65D34301-7B0C-4444-85B0-5053AA6738EA

Q37205002-66550EF1-3B50-4EE9-BB4B-55093F7FB1AE

Q37205002-6E50EEAF-8080-45E6-A313-A1C91661AE5E

P2888

Q37205002-D3F7BEC5-C46B-4BBA-B0F7-57AAF567E9FE

P304

Q37205002-5F8474DE-9AF6-4776-A0C7-635C50C4D35B

P31

Q37205002-C8BFBEF6-44E8-431C-9C8D-6F3A16274499

Q37205002-CBFA9110-D347-45F2-8AD7-68F2888E8424

P356

Q37205002-2B466FC1-A4E2-4A27-BA19-9F420515D0E6

P433

Q37205002-CDE28FA6-0523-4A7D-AF1A-15B79A5FA497

P478

Q37205002-BB7217F6-E4AB-40E4-B267-38B38091DD79

P577

Q37205002-78CA9810-2673-465F-B4D1-119F182123B0

Q37205002-7B3F506E-D59D-48A5-A0C1-58BFA7D527B6

P5875

Q37205002-D55C20C0-E313-4CEC-B811-C1845BD07B76

P698

Q37205002-8ECF6B09-38E2-473A-A498-7B3594139090

P921

Q37205002-1D797715-BAC6-4CDD-9194-B97F6495B08A

Q37205002-3E2F6FD0-CAEA-4E24-9720-A08075855B92

Q37205002-4FCD55AB-33E0-4915-B2A9-AAA2F8AB00C1

Q37205002-6989828E-5D0F-4CEC-BF1B-77191D16DCA8

Q37205002-75ED46EC-97B6-4C71-A7C8-2CB5CCE06D40

Q37205002-7E622227-4703-4092-9259-36E718CE671A

Q37205002-CE4A0BCB-C40C-42BF-85A7-9AE93E968640

P932

Q37205002-5E495094-9C07-4F1A-A390-A9183A0704F2

P356

S12185-008-0120-5

P1433

International Journal of Hematology

P1476

Body iron metabolism and pathophysiology of iron overload.

@en

P2093

Junji Kato

http://www.w3.org/2001/XMLSchema#string

Katsuya Ikuta

http://www.w3.org/2001/XMLSchema#string

Takaaki Ohtake

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Torimoto

http://www.w3.org/2001/XMLSchema#string

Yutaka Kohgo

http://www.w3.org/2001/XMLSchema#string

P2860

Hepcidin, a urinary antimicrobial peptide synthesized in the liver

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

Disorders of iron metabolism

Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells

The ferritins: molecular properties, iron storage function and cellular regulation

The beta-thalassemias.

The importance of non-transferrin bound iron in disorders of iron metabolism.

Hereditary hemochromatosis--a new look at an old disease.

Iron-chelating therapy and the treatment of thalassemia.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

P2888

s12185-008-0120-5

P304

7-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-008-0120-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2008-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5258165

http://www.w3.org/2001/XMLSchema#string

P698

18594779

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

pathophysiology

inorganic compound

human musculoskeletal system

P932

2516548

http://www.w3.org/2001/XMLSchema#string